September 2nd & 3rd 2026
Zurich, Switzerland
HealthVC Summit
Where the World’s Most Consequential Health Capital Moves.
Where the World’s Most Consequential Health Capital Moves.
HealthVC Summit brings together Europe’s most disciplined institutional investors, China’s fastest-scaling health platforms, and Saudi Arabia’s sovereign mandates, in Zurich, for two days of deal-ready dialogue that doesn’t happen anywhere else.
HealthVC Summit brings together Europe’s most disciplined institutional investors, China’s fastest-scaling health platforms, and Saudi Arabia’s sovereign mandates, in Zurich, for two days of deal-ready dialogue that doesn’t happen anywhere else.
Three Capital Corridors. One Summit. Decisions That Scale.
Three Capital Corridors. One Summit. Decisions That Scale.
ABOUT THE SUMMIT
HealthVC Summit 2026 — Zurich, Switzerland September 2nd & 3rd
HealthVC Summit 2026 — Zurich, Switzerland September 2nd & 3rd
HealthVC Summit 2026 — Zurich, Switzerland 2nd & 3rd
The global health investment landscape has fundamentally shifted. Capital is no longer confined to domestic mandates. Sovereign wealth funds in Riyadh are co-investing with Series B leads in Munich. Chinese health platforms are licensing into European digital health infrastructure. And the LP base funding the next generation of health unicorns is increasingly transnational.
The global health investment landscape has fundamentally shifted. Capital is no longer confined to domestic mandates. Sovereign wealth funds in Riyadh are co-investing with Series B leads in Munich. Chinese health platforms are licensing into European digital health infrastructure. And the LP base funding the next generation of health unicorns is increasingly transnational.
The global health investment landscape has fundamentally shifted. Capital is no longer confined to domestic mandates. Sovereign wealth funds in Riyadh are co-investing with Series B leads in Munich. Chinese health platforms are licensing into European digital health infrastructure. And the LP base funding the next generation of health unicorns is increasingly transnational.
HealthVC Summit exists for the investors who already understand this — and want to act on it.
HealthVC Summit exists for the investors who already understand this — and want to act on it.
HealthVC Summit exists for the investors who already understand this — and want to act on it.
Over two high-signal days in Zurich, we convene the senior decision-makers shaping cross-border health capital allocation: fund managers, sovereign allocators, strategic corporates, portfolio builders and the founders building the companies they are competing to back.
Over two high-signal days in Zurich, we convene the senior decision-makers shaping cross-border health capital allocation: fund managers, sovereign allocators, strategic corporates, portfolio builders and the founders building the companies they are competing to back.
Over two high-signal days in Zurich, we convene the senior decision-makers shaping cross-border health capital allocation: fund managers, sovereign allocators, strategic corporates, portfolio builders and the founders building the companies they are competing to back.
This is not a conference. It is a working summit — structured for relationship-building, deal sourcing and strategic alignment across three of the world’s most consequential health investment corridors.
This is not a conference. It is a working summit — structured for relationship-building, deal sourcing and strategic alignment across three of the world’s most consequential health investment corridors.
WHY THIS SUMMIT? WHY NOW?
The next decade of health innovation will not be won by the best technology alone. It will be won by the investors, operators and institutions that can navigate the complexity of deploying capital — and value — across geopolitical borders.
Europe’s regulatory rigour, China’s speed and scale, and Saudi Arabia’s long-horizon sovereign mandate are not competing forces. In the right hands, they are complementary. HealthVC Summit is where those hands meet.
The opportunity is specific: - Saudi Arabia’s Vision 2030 has earmarked multi-billion dollar mandates for health sector investment and diversification
China’s leading health platforms are actively seeking European clinical validation, licensing and co-development partnerships
European VCs and institutional allocators are under pressure to identify high-growth, globally scalable health assets beyond their home markets
The next decade of health innovation will not be won by the best technology alone. It will be won by the investors, operators and institutions that can navigate the complexity of deploying capital — and value — across geopolitical borders.
Europe’s regulatory rigour, China’s speed and scale, and Saudi Arabia’s long-horizon sovereign mandate are not competing forces. In the right hands, they are complementary. HealthVC Summit is where those hands meet.
The opportunity is specific: - Saudi Arabia’s Vision 2030 has earmarked multi-billion dollar mandates for health sector investment and diversification
China’s leading health platforms are actively seeking European clinical validation, licensing and co-development partnerships
European VCs and institutional allocators are under pressure to identify high-growth, globally scalable health assets beyond their home markets
The next decade of health innovation will not be won by the best technology alone. It will be won by the investors, operators and institutions that can navigate the complexity of deploying capital — and value — across geopolitical borders.
Europe’s regulatory rigour, China’s speed and scale, and Saudi Arabia’s long-horizon sovereign mandate are not competing forces. In the right hands, they are complementary. HealthVC Summit is where those hands meet.
The opportunity is specific: - Saudi Arabia’s Vision 2030 has earmarked multi-billion dollar mandates for health sector investment and diversification
China’s leading health platforms are actively seeking European clinical validation, licensing and co-development partnerships
European VCs and institutional allocators are under pressure to identify high-growth, globally scalable health assets beyond their home markets
The next decade of health innovation will not be won by the best technology alone. It will be won by the investors, operators and institutions that can navigate the complexity of deploying capital — and value — across geopolitical borders.
Europe’s regulatory rigour, China’s speed and scale, and Saudi Arabia’s long-horizon sovereign mandate are not competing forces. In the right hands, they are complementary. HealthVC Summit is where those hands meet.
The opportunity is specific: - Saudi Arabia’s Vision 2030 has earmarked multi-billion dollar mandates for health sector investment and diversification
China’s leading health platforms are actively seeking European clinical validation, licensing and co-development partnerships
European VCs and institutional allocators are under pressure to identify high-growth, globally scalable health assets beyond their home markets
If your fund or portfolio has any exposure to cross-border health strategy, the question is not whether you should be at HealthVC Summit. It is whether you can afford not to be.
WHY THIS SUMMIT? WHY NOW?
If your fund or portfolio has any exposure to cross-border health strategy, the question is not whether you should be at HealthVC Summit. It is whether you can afford not to be.
If your fund or portfolio has any exposure to cross-border health strategy, the question is not whether you should be at HealthVC Summit. It is whether you can afford not to be.
The next decade of health innovation will not be won by the best technology alone. It will be won by the investors, operators and institutions that can navigate the complexity of deploying capital — and value — across geopolitical borders.
Europe’s regulatory rigour, China’s speed and scale, and Saudi Arabia’s long-horizon sovereign mandate are not competing forces. In the right hands, they are complementary. HealthVC Summit is where those hands meet.
The opportunity is specific: - Saudi Arabia’s Vision 2030 has earmarked multi-billion dollar mandates for health sector investment and diversification
China’s leading health platforms are actively seeking European clinical validation, licensing and co-development partnerships
European VCs and institutional allocators are under pressure to identify high-growth, globally scalable health assets beyond their home markets
The next decade of health innovation will not be won by the best technology alone. It will be won by the investors, operators and institutions that can navigate the complexity of deploying capital — and value — across geopolitical borders.
Europe’s regulatory rigour, China’s speed and scale, and Saudi Arabia’s long-horizon sovereign mandate are not competing forces. In the right hands, they are complementary. HealthVC Summit is where those hands meet.
The opportunity is specific: - Saudi Arabia’s Vision 2030 has earmarked multi-billion dollar mandates for health sector investment and diversification
China’s leading health platforms are actively seeking European clinical validation, licensing and co-development partnerships
European VCs and institutional allocators are under pressure to identify high-growth, globally scalable health assets beyond their home markets
The next decade of health innovation will not be won by the best technology alone. It will be won by the investors, operators and institutions that can navigate the complexity of deploying capital — and value — across geopolitical borders.
Europe’s regulatory rigour, China’s speed and scale, and Saudi Arabia’s long-horizon sovereign mandate are not competing forces. In the right hands, they are complementary. HealthVC Summit is where those hands meet.
The opportunity is specific: - Saudi Arabia’s Vision 2030 has earmarked multi-billion dollar mandates for health sector investment and diversification
China’s leading health platforms are actively seeking European clinical validation, licensing and co-development partnerships
European VCs and institutional allocators are under pressure to identify high-growth, globally scalable health assets beyond their home markets
The next decade of health innovation will not be won by the best technology alone. It will be won by the investors, operators and institutions that can navigate the complexity of deploying capital — and value — across geopolitical borders.
Europe’s regulatory rigour, China’s speed and scale, and Saudi Arabia’s long-horizon sovereign mandate are not competing forces. In the right hands, they are complementary. HealthVC Summit is where those hands meet.
The opportunity is specific: - Saudi Arabia’s Vision 2030 has earmarked multi-billion dollar mandates for health sector investment and diversification
China’s leading health platforms are actively seeking European clinical validation, licensing and co-development partnerships
European VCs and institutional allocators are under pressure to identify high-growth, globally scalable health assets beyond their home markets
The next decade of health innovation will not be won by the best technology alone. It will be won by the investors, operators and institutions that can navigate the complexity of deploying capital — and value — across geopolitical borders.
Europe’s regulatory rigour, China’s speed and scale, and Saudi Arabia’s long-horizon sovereign mandate are not competing forces. In the right hands, they are complementary. HealthVC Summit is where those hands meet.
The opportunity is specific: - Saudi Arabia’s Vision 2030 has earmarked multi-billion dollar mandates for health sector investment and diversification
China’s leading health platforms are actively seeking European clinical validation, licensing and co-development partnerships
European VCs and institutional allocators are under pressure to identify high-growth, globally scalable health assets beyond their home markets
The next decade of health innovation will not be won by the best technology alone. It will be won by the investors, operators and institutions that can navigate the complexity of deploying capital — and value — across geopolitical borders.
Europe’s regulatory rigour, China’s speed and scale, and Saudi Arabia’s long-horizon sovereign mandate are not competing forces. In the right hands, they are complementary. HealthVC Summit is where those hands meet.
The opportunity is specific: - Saudi Arabia’s Vision 2030 has earmarked multi-billion dollar mandates for health sector investment and diversification
China’s leading health platforms are actively seeking European clinical validation, licensing and co-development partnerships
European VCs and institutional allocators are under pressure to identify high-growth, globally scalable health assets beyond their home markets
The next decade of health innovation will not be won by the best technology alone. It will be won by the investors, operators and institutions that can navigate the complexity of deploying capital — and value — across geopolitical borders.
Europe’s regulatory rigour, China’s speed and scale, and Saudi Arabia’s long-horizon sovereign mandate are not competing forces. In the right hands, they are complementary. HealthVC Summit is where those hands meet.
The opportunity is specific: - Saudi Arabia’s Vision 2030 has earmarked multi-billion dollar mandates for health sector investment and diversification
China’s leading health platforms are actively seeking European clinical validation, licensing and co-development partnerships
European VCs and institutional allocators are under pressure to identify high-growth, globally scalable health assets beyond their home markets
The next decade of health innovation will not be won by the best technology alone. It will be won by the investors, operators and institutions that can navigate the complexity of deploying capital — and value — across geopolitical borders.
Europe’s regulatory rigour, China’s speed and scale, and Saudi Arabia’s long-horizon sovereign mandate are not competing forces. In the right hands, they are complementary. HealthVC Summit is where those hands meet.
The opportunity is specific: - Saudi Arabia’s Vision 2030 has earmarked multi-billion dollar mandates for health sector investment and diversification
China’s leading health platforms are actively seeking European clinical validation, licensing and co-development partnerships
European VCs and institutional allocators are under pressure to identify high-growth, globally scalable health assets beyond their home markets
WHAT TO EXPECT
Day 1 — Investor Summit
Built for allocators, fund managers, LPs and institutional strategists.
Day 1 is a closed, high-trust environment for the institutional investor community. Every session is designed to move beyond headlines into the mechanics of cross-border deployment: co-investment structures, due diligence across regulatory regimes, risk frameworks for emerging health markets and the LP-GP dynamics reshaping fund mandates globally.
Session themes include:
The New Health Capital Axis: How Europe, China and Saudi Arabia are redefining global investment flows in healthcare
Risk, Yield and Timeline: Reconciling institutional investment horizons with health innovation realities
Co-Investment Architecture: Structuring deals across three regulatory environments without leaving value on the table
Sovereign Capital Strategy: What Gulf sovereign funds want from VC relationships — and what they will not compromise on
Market Access Pathways: The regulatory, cultural and commercial levers that determine which health companies actually scale cross-border
WHAT TO EXPECT
Day 1 — Investor Summit
Built for allocators, fund managers, LPs and institutional strategists.
Day 1 is a closed, high-trust environment for the institutional investor community. Every session is designed to move beyond headlines into the mechanics of cross-border deployment: co-investment structures, due diligence across regulatory regimes, risk frameworks for emerging health markets and the LP-GP dynamics reshaping fund mandates globally.
Session themes include:
The New Health Capital Axis: How Europe, China and Saudi Arabia are redefining global investment flows in healthcare
The New Health Capital Axis: How Europe, China and Saudi Arabia are redefining global investment flows in healthcare
Co-Investment Architecture: Structuring deals across three regulatory environments without leaving value on the table
Co-Investment Architecture: Structuring deals across three regulatory environments without leaving value on the table
Sovereign Capital Strategy: What Gulf sovereign funds want from VC relationships — and what they will not compromise on
Sovereign Capital Strategy: What Gulf sovereign funds want from VC relationships — and what they will not compromise on
Risk, Yield and Timeline: Reconciling institutional investment horizons with health innovation realities
Risk, Yield and Timeline: Reconciling institutional investment horizons with health innovation realities
Market Access Pathways: The regulatory, cultural and commercial levers that determine which health companies actually scale cross-border
Market Access Pathways: The regulatory, cultural and commercial levers that determine which health companies actually scale cross-border
Day 2 — Startup Summit
Built for founders across the health ecosystem, and the investors ready to back them. Day 2 opens the summit to a curated cohort of health founders across stages, from early conviction to growth and expansion. What matters is not stage, but relevance. Every founder in the room is building something that can extend beyond a single market. Every company has been selected for its potential to engage with cross-border capital and partnerships across Europe, China, or Saudi Arabia. This is not an open floor. It is a filtered environment. Highlights include:
Built for founders across the health ecosystem, and the investors ready to back them. Day 2 opens the summit to a curated cohort of health founders across stages, from early conviction to growth and expansion. What matters is not stage, but relevance. Every founder in the room is building something that can extend beyond a single market. Every company has been selected for its potential to engage with cross-border capital and partnerships across Europe, China, or Saudi Arabia. This is not an open floor. It is a filtered environment. Highlights include:
Startup Showcase
Structured pitch sessions across BioTech, Digital Health, MedTech, Health Data & AI
Strategic Partner Labs
Deep-dive sessions pairing founders with corporate partners, licensing prospects and distribution channels across all three regions
One-on-One Funding Clinics
Pre-scheduled, 30-minute investor meetings — no cold introductions
Sector Deep Dives
Focused roundtables on the four most active categories in cross-border health investment
FOR INVESTORS
You are deploying capital into health. Your LP base is global. Your deal flow should be too.
HealthVC Summit is designed for investors who are actively building or expanding cross-border health portfolios — and who want access to the relationships and intelligence that drive those decisions.
HealthVC Summit is designed for investors who are actively building or expanding cross-border health portfolios — and who want access to the relationships and intelligence that drive those decisions.
Who attends from the investor side: Managing Partners, CIOs and Portfolio Directors from leading European VC firms; senior allocators from Gulf sovereign and institutional funds; strategic investment leads from China’s top healthcare and life sciences groups; family office principals with active health mandates.
Who attends from the investor side: Managing Partners, CIOs and Portfolio Directors from leading European VC firms; senior allocators from Gulf sovereign and institutional funds; strategic investment leads from China’s top healthcare and life sciences groups; family office principals with active health mandates.
Investor passes are available by application. We limit delegate numbers to protect the quality of access.
What you get:
Two days of structured access to the most active sovereign allocators, co-investment partners and institutional LPs operating across Europe, China and Saudi Arabia
Pre-qualified deal flow from founders who have already cleared our curation process — stage-appropriate, regionally relevant, investment-ready
Proprietary market intelligence from fund managers and policy insiders across all three corridors
A summit partnering platform giving you full visibility into the delegate list and the ability to schedule meetings before you arrive in Zurich
Off-record roundtables structured for candid strategic dialogue — not presentations
Two days of structured access to the most active sovereign allocators, co-investment partners and institutional LPs operating across Europe, China and Saudi Arabia
Pre-qualified deal flow from founders who have already cleared our curation process — stage-appropriate, regionally relevant, investment-ready
Proprietary market intelligence from fund managers and policy insiders across all three corridors
A summit partnering platform giving you full visibility into the delegate list and the ability to schedule meetings before you arrive in Zurich
Off-record roundtables structured for candid strategic dialogue — not presentations
Investor passes are available by application. We limit delegate numbers to protect the quality of access.
Investor passes are available by application. We limit delegate numbers to protect the quality of access.
FOR STARTUPS
You have built something that works. Now you need to scale it beyond the market you started in.
The founders invited to HealthVC Summit Day 2 are not here to practice their pitch. They are here because the investors in the room are ready to move — and the partnerships available in Zurich could redefine their company’s trajectory in Europe, China or the Gulf.
We accept applications from all stages of health companies that have:
We accept applications from all stages of health companies that have:
A curated group of founders joins across stages, from early conviction bets to growth-stage companies already scaling. What matters is not stage. It is relevance. Each company in the room has a credible path to cross-border expansion and a reason to be there.
What selected startups receive:
A showcase pitch slot to a room of pre-qualified, mandate-aligned investors - Pre-scheduled one-on-one meetings with investors and strategic partners matched to your stage and sector - Access to corporate licensing, distribution and co-development conversations across all three regions - Visibility with our media and analyst partners covering global health investment
Startup places are competitive. Early applications receive priority in our matching process.
SPONSORSHIP & PARTNERSHIP
Align your brand with the capital decisions that are shaping global health.
HealthVC Summit offers a small number of category-exclusive partnerships to organisations that want meaningful, senior-level access — not logo placement.
Why partner with us:
Direct visibility with the sovereign allocators, institutional LPs, fund managers and strategic corporates who attend — an audience that cannot be reached via conventional conference marketing
Opportunities to host private roundtables, curated dinners or closed-door sessions that put your team at the centre of the most important conversations
Inclusion in our pre-summit and post-summit content programme reaching the broader global health investment community
SPONSORSHIP & PARTNERSHIP
Align your brand with the capital decisions that are shaping global health.
HealthVC Summit offers a small number of category-exclusive partnerships to organisations that want meaningful, senior-level access — not logo placement.
Why partner with us:
Direct visibility with the sovereign allocators, institutional LPs, fund managers and strategic corporates who attend — an audience that cannot be reached via conventional conference marketing
Opportunities to host private roundtables, curated dinners or closed-door sessions that put your team at the centre of the most important conversations
Inclusion in our pre-summit and post-summit content programme reaching the broader global health investment community
SPONSORSHIP & PARTNERSHIP
Align your brand with the capital decisions that are shaping global health.
HealthVC Summit offers a small number of category-exclusive partnerships to organisations that want meaningful, senior-level access — not logo placement.
Why partner with us:
Direct visibility with the sovereign allocators, institutional LPs, fund managers and strategic corporates who attend — an audience that cannot be reached via conventional conference marketing
Opportunities to host private roundtables, curated dinners or closed-door sessions that put your team at the centre of the most important conversations
Inclusion in our pre-summit and post-summit content programme reaching the broader global health investment community
Sponsorship tiers and partnership packages are available on request. We work with a limited number of partners per edition to ensure category exclusivity and genuine strategic value.
Sponsorship tiers and partnership packages are available on request. We work with a limited number of partners per edition to ensure category exclusivity and genuine strategic value.
Sponsorship tiers and partnership packages are available on request. We work with a limited number of partners per edition to ensure category exclusivity and genuine strategic value.
LOCATION
Zurich, Switzerland September 2nd & 3rd, 2026
Zurich is not a coincidence. It is a deliberate choice.
As one of the world’s foremost financial centres — neutral, stable, internationally connected — Zurich provides the infrastructure and the institutional credibility that a summit focused on cross-border capital deployment demands. It sits at the intersection of Europe’s major health innovation corridors, is a short flight from Gulf hubs, and carries the regulatory and financial heritage that institutional investors from all three of our target regions respect.
Venue details and accommodation recommendations will be shared with registered delegates.
LOCATION
Zurich, Switzerland September 2nd & 3rd, 2026
Zurich is not a coincidence. It is a deliberate choice.
As one of the world’s foremost financial centres — neutral, stable, internationally connected — Zurich provides the infrastructure and the institutional credibility that a summit focused on cross-border capital deployment demands. It sits at the intersection of Europe’s major health innovation corridors, is a short flight from Gulf hubs, and carries the regulatory and financial heritage that institutional investors from all three of our target regions respect.
Venue details and accommodation recommendations will be shared with registered delegates.
LOCATION
Zurich, Switzerland September 2nd & 3rd, 2026
Zurich is not a coincidence. It is a deliberate choice.
As one of the world’s foremost financial centres — neutral, stable, internationally connected — Zurich provides the infrastructure and the institutional credibility that a summit focused on cross-border capital deployment demands. It sits at the intersection of Europe’s major health innovation corridors, is a short flight from Gulf hubs, and carries the regulatory and financial heritage that institutional investors from all three of our target regions respect.
Venue details and accommodation recommendations will be shared with registered delegates.
FREQUENTLY ASKED QUESTIONS
Who is HealthVC Summit designed for?
How are investor passes allocated?
How are startups selected?
What sectors does the summit cover?
Is there a partnering platform?
Can I attend just one day?